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Protein Damage and Antioxidant Status Alterations 
Caused by Oxidative Injury in Chronic Myeloid Leukemia
INTRODUCTION
Chronic myeloid leukemia (CML) was the first human 
malignancy shown to be consistently associated with 
a chromosomal abnormality, the Philadelphia chromo-
some (Nowell and Hungerford, 1960). At the gene level, 
the Philadelphia chromosome is the result of breaks 
on chromosomes 9 and 22 with a reciprocal transloca-
tion of the distal genetic material (Rowley, 1973). This 
translocation transposes the c-abl proto-oncogene from 
its normal location on chromosome 9 to a new posi-
tion on chromosome 22, in proximity to the breakpoint 
cluster region (bcr). This forms the new hybrid BCR-ABL 
oncogene, an abnormal 8.5-kb RNA that encodes for a 
210-kDa fusion protein, which, presumably through its 
increased tyrosine kinase activity, changes normal hema-
topoietic cells into CML cells (Nowell and Hungerford, 
1960; Rowley, 1973; Shtivelman et al., 1985; Kurzrock et 
al., 2003).
Oxidative stress is a biochemical condition that occurs 
when intracellular antioxidants are unable to neutral-
ize pro-oxidants such as reactive oxidant species (ROS). 
These ROS damage membranes, DNA, lipids, proteins, 
and carbohydrates, eventually causing cell injury and 
death. They also accelerate the development of age-
related chronic diseases such as cancer and cardiovascu-
lar disease (Halliwell and Gutteridge, 1999; Galli et al., 
2005; Frei, 1994). ROS contribute to several cellular func-
tions, including the regulation of signal transduction, 
gene expression, and proliferation (Alvarez-Gonzalez, 
1999). The biological effects of ROS vary widely in differ-
ent cells, and include modulation of signaling pathways 
by directly altering the activity of protein kinases and 
protein phosphatases.
The objective of our study was to measure the intensity 
of oxidative damage at the cellular and molecular levels 
through measurements of lipid peroxidation and pro-
tein carbonyls. The study also aimed to investigate the 
oxidative profile in CML patients through the verifica-
tion of main enzymatic antioxidant defenses (catalase 
[CAT] and superoxide dismutase [SOD]), nonenzymatic 
antioxidants (vitamins A and E), and essential micronu-
trients (selenium, magnesium, and zinc) in the blood of 
CML patients. Our study demonstrated that BCR/ABL 
translocation in CML may be associated with increased 
intracellular levels of ROS.
METHODS 
Study Cohort
Our study subjects consisted of 40 clinically diagnosed 
CML patients who reported for treatment at the Banaras 
Hindu University Hospital Department of Medicine in 
Varanasi. Our controls consisted of 40 age- and sex-
matched healthy volunteers of a socioeconomic status 
similar to that of the patients. None of the control sub-
jects had any acute or chronic diseases such as diabetes, 
parasitosis, or immune dysfunction. All of the control 
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Objective: To evaluate the oxidative stress and antioxidant 
defense in patients with chronic myeloid leukemia.
Background: Chronic myeloid leukemia is a myeloprolifera-
tive disorder associated with a characteristic chromosomal 
translocation called the Philadelphia chromosome. Reactive 
oxygen species and other free radicals mediate phenotypic 
and genotypic changes leading from mutation to neoplasia in 
all cancers, including chronic myeloid leukemia. We evaluated 
patients with chronic myeloid leukemia by observing their oxi-
dative status and antioxidant defense.
Methods: Using serum from 40 clinically diagnosed cases 
of chronic myeloid leukemia as well as 40 healthy controls, 
we measured the concentration of thiobarbituric acid, levels 
of protein carbonylation, total antioxidant status, catalase, 
superoxide dismutase, glutathione peroxidase, vitamins A and 
E, and the trace elements zinc, magnesium, and selenium. 
Results: We found significantly increased levels of serum mal-
onyldialdehyde and protein carbonyl in patients with chronic 
myeloid leukemia in comparison to healthy individuals, and 
significantly decreased levels of the antioxidants and micro-
nutrients thiobarbituric acid, catalase, superoxide dismutase, 
glutathione peroxidase, vitamins A and E, zinc, magnesium, 
and selenium. These data suggest cellular damage occurring 
at the level of lipids and proteins.
Conclusion: These findings indicate a link between low levels 
of antioxidants and cellular damage in patients with chronic 
myeloid leukemia, supporting the idea that oxidative stress 
may play a role in the pathogenesis of chronic myeloid leu-
kemia.
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subjects had normal blood cell counts, including leuko-
cytes, and were not undergoing any pharmacological 
therapy. Venous blood was collected from the patients 
and healthy volunteers in sterile tubes and the serum 
was separated for various biochemical and hematologi-
cal investigations. 
Presence of the characteristic Philadelphia chromo-
some was established by standard methods at the 
Chromosomal & Molecular Genetic Diagnostic Unit, 
Department of Zoology, Faculty of Science, Banaras 
Hindu University, Varanasi, India.
Written informed consent for the study was obtained 
from each patient and healthy subject with the approval 
of the ethical committee of the Institute of Medical 
Sciences, Banaras Hindu University.
Reagents
All chemicals and reagents used in the study were of 
analytical grade from Sigma-Aldrich Co. (USA).
Evaluation of Oxidative Stress, Protein Damage, and 
Antioxidant Status
Oxidative status of the serum of patients and con-
trols was assessed by measuring serum lipid peroxida-
tion levels by the thiobarbituric acid (TBARS) method 
(Buegeand Aust, 1978). Protein damage was assessed by 
measuring serum levels of protein carbonyls by a spec-
trophotometric detection of the reaction of 2,4-dinitro-
phenyl hydrazine (DNPH) with protein carbonyl to form 
protein hydrazine (Levine et al., 1990). Total protein 
content was measured using a colorimetric kit based on 
the biuret method. Total antioxidant status in serum was 
determined by a spectrophotometric method using the 
Randox assay kit (Miller et al., 1993).
Enzymatic Antioxidants Assay
SOD activity was measured based on the ability of 
the enzyme to inhibit the auto-oxidation of pyrogal-
lol (Marklund and Marklund, 1974). Glutathione (GSH) 
determination was performed using Ellman’s reagent 
(Beutler et al., 1963). CAT activity was assayed by the 
decomposition of hydrogen peroxide (Aebi, 1983). 
Assay of Nonenzymatic Antioxidants
Vitamin A and E levels were measured by spectrophoto-
metric standard methods (Bessey et al., 1946; Paterson 
and Wiggins, 1954; Quaife and Dju, 1949). Selenium lev-
els were measured by the spectrophotometric method 
using azo dye (Khanna et al., 2010). Magnesium levels 
were measured using a colorimetric kit based on the 
calamagite method (Gindler and Heth, 1971). Zinc levels 
were also measured using a colorimetric kit (Abe et al., 
1989; Makino, 1999). 
Statistical Analysis
Statistical analysis was performed by SPSS 16.0. All 
data were expressed as the mean ± standard deviation. 
Statistical significance was evaluated by independent 
t-test. All statistical analyses were two-tailed and a value 
of p <0.05 was considered statistically significant.
RESULTS
The characteristic features of the patients and controls 
are given in Table 1. The mean age of the CML patients 
was 36.7 ± 11.9 years. The mean leukocyte count was 
80,410 per mm3. The mean spleen size measured by 
ultrasonography of patients was 21.1 ± 3.5 cm, and 
was found to be significantly larger than controls. The 
Philadelphia chromosome was present in all 40 patients 
with CML, which confirms the BCR/ABL translocation.
Lipid peroxidation was evaluated by measuring the levels 
of malondialdehyde (MDA) in terms of TBARS, and pro-
tein damage was assessed by measuring protein carbon-
yls (PC), which are products of irreversible nonenzymatic 
protein oxidation. The mean level of MDA was signifi-
cantly higher in CML cases as compared to control cases. 
The elevated levels of MDA in patients are a marker of 
increased lipid peroxidation or oxidative stress. The lev-
els of protein carbonyl were also elevated significantly 
in comparison to the normal controls, as shown in Table 
2. On the other hand, the levels of serum total antioxi-
dant status (TAS) in CML cases were lower than in the 





Mean Age (year) 37.3 ± 11.6 36.7 ± 11.9
Mean Duration of Symptoms 
(months)
N/A 3.4 ± 1.9
Mean Spleen Size (cm) 10 ± 0.5 21.1 ± 3.5
Mean Hemoglobin (gm/dl) 12.5 ± 1.2 11.14 ± 1.68
Mean Leukocyte Count (per mm3) 7,600 80,410
Mean Creatinine (mg/dl) 0.90 ± 0.19 0.85 ± 0.12
Ph Chromosomes(+) N/A 40 (100%)
TABLE 2. LEVELS OF OXIDATIVE STRESS AND PROTEIN 








0.02 ± 0.18 3.91 ± 0.203 0.002
Protein Carbonyl 
(nmol/mg of protein)
1.32 ± 0.76 1.79 ± 0.13 0.003
Values are given as mean ± SEM. *Statistical analysis was done by independent 
Student’s t-test. All statistical analyses were two-tailed and a value of p <0.05 was 
considered statistically significant.
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control group. The enzymatic antioxidants SOD, reduced 
GPx, and CAT likewise were found to be lower in patients 
relative to controls, as shown in Table 3.
The levels of vitamins A and E were significantly lower 
in CML cases compared to controls, although values for 
both the CML cases and the controls were within normal 
reference intervals. Serum levels of the important trace 
elements selenium, magnesium, and zinc were signifi-
cantly lower in CML patients as compared to controls.
These observations suggest that oxidative stress can 
release catalytic trace elements from tissues. This may 
initiate a vicious cycle of free-radical generation, caus-
ing imbalance in enzymatic and nonenzymatic antioxi-
dant defense mechanisms. 
DISCUSSION
Free radicals are implicated in the pathogenesis of tis-
sue injury in many human diseases. The disturbance 
of the pro-oxidant/antioxidant balance, resulting from 
increased free-radical production, antioxidant enzyme 
inactivation, and excessive antioxidant consumption, 
is the causative factor in oxidative damage. These free 
radicals set up a chain reaction that changes cell per-
meability, denatures proteins, alters enzyme activity, 
decreases neurotransmitter transmission, causes break-
age of DNA, and degrades structural proteins. Thus, 
free radicals are directly responsible for causing genetic 
mutations and carcinogenesis. The body has multiple 
defense mechanisms against free radical–mediated tis-
sue damage. Among them, antioxidants are the primary 
lines of defense. Under normal circumstances, there is a 
critical balance between pro-oxidizing and antioxidizing 
forces. Antioxidants interact with free radicals in several 
ways, controlling damaging chain reactions. Examples 
of antioxidants include vitamins A and E, SOD, CAT, GPx, 
bilirubin, and uric acid (Shtivelman et al., 1985). 
Cancer cells under sustained ROS stress tend to heavily 
utilize adaptation mechanisms and may exhaust cellular 
ROS-buffering capacity. A relationship between leuke-
mia and oxidative stress has been observed. Leukemic 
cells produce higher amounts of ROS than nonleukemic 
cells because the former are experiencing sustained oxi-
dative blockade (Al-Gayyar et al., 2007).
It has been suggested that ROS exert their cytotoxic 
effect by carbonylating proteins, leading to a loss of 
protein function. Protein dysfunction is considered to be 
a widespread marker of severe oxidative stress, damage, 
and disease. ROS also cause peroxidation of membrane 
phospholipids, changing the permeability of the cellu-
lar membrane, increasing membrane fluidity and rigid-
ity, and in some cases increasing the risk of membrane 
rupture. Our findings are in broad agreement with an 
earlier study carried out on CML patients that suggests 
that accumulation of ROS may result in significantly 
increased lipid peroxidation and protein damage at the 
cellular and molecular levels (Singh et al., 2009; Tandon 
et al.et al., 2002).
Our study also found that CML patients were lacking in 
key antioxidant enzymes and essential micronutrients, 
which act as the first line of defense against free radicals 
and ROS. SOD efficiently removes the superoxide radi-
cal by converting it to H2O2, which in turn is metabo-
lized by GPx and CAT to molecular oxygen and water. 
With reduced antioxidant enzyme activities, the body is 
unable to dispose of the superoxide radical and H2O2, 
which can attack biological molecules, leading to exten-
sive tissue damage. Divalent ions of transition metals can 
TABLE 3. ENZYMATIC ANTIOXIDANT, NONENZYMATIC ANTIOXIDANT, AND TRACE-ELEMENT ANTIOXIDANT LEVELS IN CML 
PATIENTS AND CONTROL CASES
Parameters Control (n=40) Cases (n=40) p-value*
TAS (mmol/l) 1.81 ± 0.06 1.49 ± 0.09 0.007
Enzymatic Antioxidants
Catalase (units/ml) 33.32 ± 1.49 27.43 ± 1.43 0.006
SOD (units/ml ) 149.79 ± 6.26 87.62 ± 6.59 0.0001
GPx (units/dl of hemolysate) 51.25 ± 2.96 38.80 ± 3.66 0.01
Nonenzymatic Antioxidants
Vitamin A (μg/dl) 45.84 ±1.63 38.24 ± 2.52 0.01
Vitamin E (mg/l) 13.09 ± 0.51 10.96 ± 0.71 0.01
Trace Elements
Zinc (μg/dl ) 87.69 ± 3.67 75.96 ± 2.50 0.01
Magnesium (mg/l) 31.05 ± 0.97 27.44 ± 0.072 0.004
Selenium (μg/l) 38.90 ± 4.67 25.52 ± 0.795 0.006
Values are given as mean ± SEM. *Statistical analysis was done by independent Student t-test.  
All statistical analyses were two-tailed and a value of p <0.05 was considered statistically significant.
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promote lipid peroxidation in vitro, and much attention 
is currently focused on lipid peroxidation in the patho-
genesis of metal toxicity. The mechanism of pathogene-
sis could be mediated by direct effects of trace elements 
such as zinc, magnesium, and selenium on the formation 
of hydroxyl free radicals from hydrogen peroxide and 
superoxide via the Fenton and Haber-Weiss reactions 
(Zuo et al., 2006; Dalle-Donne et al., 2006; Prasad, 1991). 
Many antioxidants are micronutrients or depend on 
micronutrients for their activity. These include vitamins 
A and E as well as trace elements such as zinc, mag-
nesium, and selenium, which act as cofactors for anti-
oxidant enzymes. In our study, we observed that the 
activity of SOD, CAT, GPx, trace elements, and vitamins 
was significantly decreased in CML patients as compared 
to controls. These findings suggest that alterations in 
antioxidant defenses, which normally protect biological 
tissues from ROS, may be related to leukemia progres-
sion. Alternatively, it is possible that the cancer process 
itself causes the observed dysfunction of the antioxidant 
system.
In conclusion, although reactive species are well rec-
ognized for playing a dual role—deleterious and ben-
eficial—excessive accumulation of ROS contributes to 
antioxidant depletion and dysfunction. Genomic insta-
bility is manifested by the accumulation of chromosomal 
aberrations and mutations leading to the malignant 
progression of disease. Research evidence suggests 
that abnormalities in protein translation, modification 
(mainly phosphorylation), and degradation of DNA play 
critical roles in the initiation, development, and induc-
tion of the BCR/ABL transformation. Although these 
modifications can be removed efficiently by DNA repair 
mechanisms, a persistent increase in ROS could lead to 
an accumulation of mutations (Spencer et al., 1995). 
Increased levels of oxidative damage and decreased 
levels of the antioxidant system in the CML patients in 
the present study suggest that BCR/ABL transformed 
leukemia cells display higher levels of oxidative stress. In 
addition, it is possible that the BCR/ABL transformation 
affects the protein levels or enzymatic activity of one or 
more enzymes that regulate ROS. 
Thus, there may be a link between decreased antioxidant 
levels and increased cellular alterations due to oxidative 
damage, supporting the possibility of the persistence of 
oxidative stress in CML. More studies are necessary to 
confirm whether these alterations are the cause or the 
consequence of carcinogenesis.
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